se of photoliasis and topical antioxidants in the treatment of actinic keratosis and skin cancer field: a randomized controlled trial
- Conditions
- actinic keratosisL57.0
- Registration Number
- RBR-957zf2
- Lead Sponsor
- Faculdade de Medicina de Botucatu - UNESP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Sign the Informed Consent Form; Age between 50 and 90 years of both sexes; Present at least three and at most ten lesions clinically compatible with actinic keratosis in each forearm, bilaterally.
Fewer than three or more than ten injuries in each forearm; Selected treatment area that has atypical clinical appearance or other extensive forearm dermatoses; Current and prior clinical diagnosis or evidence of any medical condition that exposes the patient to increased risks, interferes with the safety or efficacy of the proposed treatment; Have hypersensitivity or allergy to any of the subtances under study; Patients using any systemic or topical immunosuppressive substance, oral retinoid, and other local treatments (eg corticosteroids, anti-inflammatory drugs, retinoids); Immunocompromised individuals; Coagulation disorders; Suspected or confirmed pregnancy. Note: Women of childbearing age should receive urinary Beta HCG at the beginning of treatment to exclude incipient pregnancy; Women of childbearing age who do not use contraception;
Breastfeeding women
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method